Mankind has MKP10241, a small-molecule oral obesity drug, in Phase II in Australia
Most patients experience diarrhea for 28 weeks during dose escalation, with symptoms improving as the body adapts
Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O, Maluenda F, Diaz JC, Rencoret G, Braghetto I, Castillo J, Poniachik J, Videla LA
Injection Technique and Timing Both Retatrutide and Mounjaro are administered via once-weekly subcutaneous injection
Researchers must observe the following precautions at all times
Many industry watchers are questioning whether policies enacted this year will ultimately lead to better growth going forward, especially for the average stock